Pathogenesis and Treatment of Usher Syndrome Type IIA.

Zaw, Khine; Carvalho, Livia S; Aung-Htut, May T; Fletcher, Sue; Wilton, Steve D; Chen, Fred K; McLenachan, Samuel

Zaw, Khine; Carvalho, Livia S; Aung-Htut, May T; Fletcher, Sue; Wilton, Steve D; Chen, Fred K; McLenachan, Samuel.

Afiliação

Zaw K; Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia.
Carvalho LS; Lions Eye Institute, Nedlands, Western Australia, Australia.
Aung-Htut MT; Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Fletcher S; Lions Eye Institute, Nedlands, Western Australia, Australia.
Wilton SD; Centre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, Western Australia, Australia.
Chen FK; Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia.
McLenachan S; Perron Institute for Neurological and Translational Science, University of Western Australia, Nedlands, Western Australia, Australia.

Asia Pac J Ophthalmol (Phila) ; 11(4): 369-379, 2022.

Article em En | MEDLINE | ID: mdl-36041150

Assuntos

Retinose Pigmentar; Síndromes de Usher; Animais; Humanos; Mutação; Retina; Retinose Pigmentar/genética; Síndromes de Usher/diagnóstico; Síndromes de Usher/genética; Síndromes de Usher/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinose Pigmentar / Síndromes de Usher Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinose Pigmentar / Síndromes de Usher Idioma: En Ano de publicação: 2022 Tipo de documento: Article